{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T19:40:03Z","timestamp":1756323603127,"version":"3.44.0"},"reference-count":25,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,3,8]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>We report a case of periocular squamous cell carcinoma invading the anterior orbit that significantly reduced in size and regressed from invasive to in situ following treatment with oral acitretin, a second-generation retinoid. The residual in situ disease was then successfully treated with cryotherapy and the patient remains in remission 12 months following cessation of systemic acitretin.<\/jats:p>","DOI":"10.1136\/bcr-2020-241167","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T12:37:57Z","timestamp":1619008677000},"page":"e241167","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Systemic acitretin in the management of periocular squamous cell carcinoma"],"prefix":"10.1136","volume":"14","author":[{"given":"Haoyu","family":"Wang","sequence":"first","affiliation":[{"name":"Ophthalmology Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1011-6915","authenticated-orcid":false,"given":"Bashar","family":"Bata","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"},{"name":"Oncology and Metabolism, The University of Sheffield, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zanna","family":"Currie","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Salvi","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"},{"name":"Oncology and Metabolism, The University of Sheffield, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Tan","sequence":"additional","affiliation":[{"name":"Ophthalmology Department, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"key":"2025082711594151000_14.4.e241167.1","first-page":"1","article-title":"Epibulbar carcinoma","volume":"22","author":"Ni","year":"1982","journal-title":"Int Ophthalmol Clin"},{"key":"2025082711594151000_14.4.e241167.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90161-6"},{"key":"2025082711594151000_14.4.e241167.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2004.02.009"},{"key":"2025082711594151000_14.4.e241167.4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(84)90385-4"},{"key":"2025082711594151000_14.4.e241167.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.1982.tb00317.x"},{"key":"2025082711594151000_14.4.e241167.6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0002-9394(14)71523-5","article-title":"Clinical characteristics associated with orbital invasion of cutaneous basal cell and squamous cell tumors of the eyelid","volume":"113","author":"Howard","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"2025082711594151000_14.4.e241167.7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/eye.2016.218","article-title":"Orbital exenteration for advanced periorbital non-melanoma skin cancer: prognostic factors and survival","volume":"31","author":"Gerring","year":"2017","journal-title":"Eye"},{"key":"2025082711594151000_14.4.e241167.8","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.1995.13.8.1933","article-title":"Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study","volume":"13","author":"Bavinck","year":"1995","journal-title":"J Clin Oncol"},{"key":"2025082711594151000_14.4.e241167.9","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01831-0"},{"key":"2025082711594151000_14.4.e241167.10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-0960.2002.00613.x"},{"key":"2025082711594151000_14.4.e241167.11","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)01587-1"},{"key":"2025082711594151000_14.4.e241167.12","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1002\/cncr.26374","article-title":"Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North central cancer treatment group study 969251)","volume":"118","author":"Kadakia","year":"2012","journal-title":"Cancer"},{"key":"2025082711594151000_14.4.e241167.13","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/84.4.235"},{"key":"2025082711594151000_14.4.e241167.14","unstructured":"Zito PM , Acitretin MT . Statpearls. Treasure Island (FL): StatPearls Publishing LLC, 2020."},{"key":"2025082711594151000_14.4.e241167.15","doi-asserted-by":"publisher","DOI":"10.1038\/35106036"},{"key":"2025082711594151000_14.4.e241167.16","first-page":"161","article-title":"Preventative effect of etretinate therapy on multiple actinic keratoses","volume":"9","author":"Watson","year":"1986","journal-title":"Cancer Detect Prev"},{"key":"2025082711594151000_14.4.e241167.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2004.30152.x"},{"key":"2025082711594151000_14.4.e241167.18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/jdt.14.s2.3.6","article-title":"Acitretin suppression of squamous cell carcinoma: case report and literature review","volume":"14","author":"Lebwohl","year":"2003","journal-title":"J Dermatolog Treat"},{"key":"2025082711594151000_14.4.e241167.19","doi-asserted-by":"crossref","unstructured":"Li Y-Y SY-L , Zhang B-L , et al . Treatment of multiple bowen\u2019s disease with squamous cell and basal cell carcinomas with oral acitretin combined with excision. Dermatologica Sinica 2014;32.doi:10.1016\/j.dsi.2013.09.001","DOI":"10.1016\/j.dsi.2013.09.001"},{"key":"2025082711594151000_14.4.e241167.20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/CEJ0b013e3283481ddc","article-title":"Efficacy of acitretin in the treatment of squamous cell carcinoma of the oral cavity","volume":"20","author":"Carlesimo","year":"2011","journal-title":"Eur J Cancer Prev"},{"key":"2025082711594151000_14.4.e241167.21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/oxfordjournals.annonc.a058881","article-title":"Efficacy of recombinant alpha-interferon 2A and 13-cis-retinoic acid in the treatment of squamous cell carcinoma","volume":"5","author":"Toma","year":"1994","journal-title":"Ann Oncol"},{"key":"2025082711594151000_14.4.e241167.22","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12766"},{"key":"2025082711594151000_14.4.e241167.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(01)00796-5"},{"key":"2025082711594151000_14.4.e241167.24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bjd.19621","article-title":"British association of dermatologists guidelines for the management of people with cutaneous squamous cell carcinoma 2020","volume":"184","author":"Keohane","year":"2021","journal-title":"Br J Dermatol"},{"key":"2025082711594151000_14.4.e241167.25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/DSS.0000000000001558","article-title":"Acitretin-altered squamous cell carcinoma: a pitfall in diagnosis","volume":"45","author":"Koh","year":"2019","journal-title":"Dermatol Surg"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-241167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T18:59:48Z","timestamp":1756321188000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-241167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4,21]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bcr-2020-241167"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-241167","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}